SINGAPORE
Singapore | New Patents and Trade Marks Acceleration Programmes
UPDATE 5/1/26: The Intellectual Property Office of Singapore (IPOS) has suspended the acceptance of new acceleration requests from 4 January 2026 until further notice. Requests received before 4 January...
UPDATE 5/1/26: The Intellectual Property Office of Singapore (IPOS) has suspended the acceptance of new acceleration requests from 4...
Read More
AUSTRALIA
Australia | Patent term extensions – Insights from recent Federal Court decisions
Over recent years, Australian courts have heard a growing number of challenges to pharmaceutical patent term extensions (PTEs). The decisions in these cases signal an increasingly contentious landscape for...
Over recent years, Australian courts have heard a growing number of challenges to pharmaceutical patent term extensions (PTEs). The...
Read More
AUSTRALIA
Australia | AI-powered Medical Devices: Tipping the scales in favour of patent eligibility
Key takeaways The Australian regulatory framework for medical devices provides useful, practical guidance for patenting inventions involving Artificial Intelligence (AI) within the medical technology (medtech) space. Whilst there is no statutory...
Key takeaways The Australian regulatory framework for medical devices provides useful, practical guidance for patenting inventions involving Artificial Intelligence (AI)...
Read More
GREATER CHINA
China | Establishing Inventive Step in Swiss-Type Use Claims – A Case Study on Disease Subtypes and Known APIs
As pharmaceutical innovation increasingly targets specific disease subtypes and personalised therapies, patent protection strategies must evolve accordingly—especially in jurisdictions like China, where method of treatment claims are not patentable. This...
As pharmaceutical innovation increasingly targets specific disease subtypes and personalised therapies, patent protection strategies must evolve accordingly—especially in jurisdictions...
Read More
GREATER CHINA
Is it important to build a SEP portfolio?
In an interconnected world, technological standards such as 5G, Wi-Fi, and Bluetooth play a crucial role in ensuring interoperability within global technology ecosystems. Technology companies that develop and protect...
In an interconnected world, technological standards such as 5G, Wi-Fi, and Bluetooth play a crucial role in ensuring interoperability...
Read More
GREATER CHINA
China | Patent Examination Guidelines – draft amendments to provisions of AI and bitstream related inventions
On 30 April 2025, the China National Intellectual Property Administration (CNIPA) released a Draft Amendments to Patent Examination Guidelines (for Public Comments). The proposed amendments provide further clarification on...
On 30 April 2025, the China National Intellectual Property Administration (CNIPA) released a Draft Amendments to Patent Examination Guidelines...
Read More
GREATER CHINA
China | Insights from CIPIS 2025
The 22nd China Intellectual Property & Innovation Summit (CIPIS) held in Shanghai brought together legal professionals, in-house counsel, and industry thought leaders to exchange perspectives on the future of...
The 22nd China Intellectual Property & Innovation Summit (CIPIS) held in Shanghai brought together legal professionals, in-house counsel, and...
Read More
AUSTRALIA
Can patient data be used to train AI?
Key takeaways Inventors and Applicants need to ensure that the data used to support their patent applications comply with relevant laws relating to the use of patient data, such as...
Key takeaways Inventors and Applicants need to ensure that the data used to support their patent applications comply with relevant...
Read More
GREATER CHINA
China | Good faith principle for patent applications
The principle of ‘good faith’ plays a crucial role in ensuring the integrity and reliability of patent applications. This principle is particularly emphasised in China's patent law, where adherence...
The principle of ‘good faith’ plays a crucial role in ensuring the integrity and reliability of patent applications. This...
Read More
AUSTRALIA
Australia | Sanofi v Amgen dispute update
Federal Court dismisses Sanofi’s appeal and orders that Amgen’s Repatha patent applications proceed to grant, offering key lessons for other antibody patents approaching the end of their term. The global...
Federal Court dismisses Sanofi’s appeal and orders that Amgen’s Repatha patent applications proceed to grant, offering key lessons for...
Read More